These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35150232)

  • 21. Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices.
    Adatya S; Sunny R; Fitzpatrick MJ; Colvin M; Thennapan T; John R; Dodge Zantek N; Pritzker M; Eckman P; Uriel N
    J Heart Lung Transplant; 2016 Nov; 35(11):1311-1320. PubMed ID: 27836023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of APTT factor sensitivity--the misguiding guideline.
    Lawrie AS; Kitchen S; Efthymiou M; Mackie IJ; Machin SJ
    Int J Lab Hematol; 2013 Dec; 35(6):652-7. PubMed ID: 23718922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
    Riano I; Prasongdee K
    J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method.
    Tripodi A; Poggio M; Scapellato L; Mannucci PM
    Haemostasis; 1989; 19(4):205-12. PubMed ID: 2509308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
    Shetty S; Ghosh K; Mohanty D
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):493-7. PubMed ID: 12851537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples).
    He S; Eelde A; Petrini P; Wallen H; Gabrielsson L; Svensson J; Blombäck M; Holmström M
    Thromb Res; 2018 Nov; 171():7-13. PubMed ID: 30216822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of factor VIII:C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents.
    Mischke R
    Haemophilia; 2000 May; 6(3):135-9. PubMed ID: 10792470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.
    Toulon P; Eloit Y; Smahi M; Sigaud C; Jambou D; Fischer F; Appert-Flory A
    Int J Lab Hematol; 2016 Aug; 38(4):389-96. PubMed ID: 27185477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?
    Martinuzzo M; Barrera L; Rodriguez M; D'Adamo MA; López MS; Otaso JC
    Int J Lab Hematol; 2015 Dec; 37(6):853-60. PubMed ID: 26338156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
    Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
    Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of Routine Coagulation Tests in Healthy Children Undergoing Elective Minor Surgery: a 12-Year Retrospective Study.
    Song J; Jung HW; Lee EH; Chang HK; Yoon HS
    Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.
    Scand J Haematol; 1980 Oct; 25(4):308-17. PubMed ID: 6782653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies.
    Bowyer A; Kitchen S; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):154-8. PubMed ID: 20840376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Danazol-induced factor VIII and IX bypassing activity in hemophiliacs.
    Garewal HS; Corrigan JJ; Jeter MA; Damiano ML; Durie BG
    Thromb Res; 1985 Jul; 39(1):117-25. PubMed ID: 3929420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New quantitative aPTT waveform analysis and its application in laboratory management of haemophilia A patients.
    Milos M; Coen Herak D; Zupancic-Salek S; Zadro R
    Haemophilia; 2014 Nov; 20(6):898-904. PubMed ID: 25273337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
    Murray D; Pennell B; Olson J
    Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review.
    Rasmussen KL; Philips M; Tripodi A; Goetze JP
    Eur J Haematol; 2020 Jun; 104(6):519-525. PubMed ID: 32049377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.